NO315517B1 - Polypeptid som er i stand til a gjenkjenne og selektivt binde humant FSH, DNA som koder for dette, rekombinant ekspresjonsvektor inneholdende dette DNA, celle transfektert med ekspresjonsvektoren, fremgangsmate for fremstilling av polypeptidet, farmasoyti - Google Patents

Polypeptid som er i stand til a gjenkjenne og selektivt binde humant FSH, DNA som koder for dette, rekombinant ekspresjonsvektor inneholdende dette DNA, celle transfektert med ekspresjonsvektoren, fremgangsmate for fremstilling av polypeptidet, farmasoyti Download PDF

Info

Publication number
NO315517B1
NO315517B1 NO19933272A NO933272A NO315517B1 NO 315517 B1 NO315517 B1 NO 315517B1 NO 19933272 A NO19933272 A NO 19933272A NO 933272 A NO933272 A NO 933272A NO 315517 B1 NO315517 B1 NO 315517B1
Authority
NO
Norway
Prior art keywords
fsh
receptor
polypeptide
fragment
mutant
Prior art date
Application number
NO19933272A
Other languages
English (en)
Norwegian (no)
Other versions
NO933272D0 (no
NO933272L (no
Inventor
Christie Ann Kelton
Patrice Noreen Nugent
Rene Lynn Schweickhardt
Shirley Vui Yen Cheng
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24688922&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO315517(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO933272D0 publication Critical patent/NO933272D0/no
Publication of NO933272L publication Critical patent/NO933272L/no
Publication of NO315517B1 publication Critical patent/NO315517B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19933272A 1991-03-15 1993-09-14 Polypeptid som er i stand til a gjenkjenne og selektivt binde humant FSH, DNA som koder for dette, rekombinant ekspresjonsvektor inneholdende dette DNA, celle transfektert med ekspresjonsvektoren, fremgangsmate for fremstilling av polypeptidet, farmasoyti NO315517B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67008591A 1991-03-15 1991-03-15
PCT/US1992/000122 WO1992016620A1 (fr) 1991-03-15 1992-01-02 Recepteur de l'hormone folliculostimulante humaine

Publications (3)

Publication Number Publication Date
NO933272D0 NO933272D0 (no) 1993-09-14
NO933272L NO933272L (no) 1993-09-14
NO315517B1 true NO315517B1 (no) 2003-09-15

Family

ID=24688922

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19933272A NO315517B1 (no) 1991-03-15 1993-09-14 Polypeptid som er i stand til a gjenkjenne og selektivt binde humant FSH, DNA som koder for dette, rekombinant ekspresjonsvektor inneholdende dette DNA, celle transfektert med ekspresjonsvektoren, fremgangsmate for fremstilling av polypeptidet, farmasoyti

Country Status (19)

Country Link
US (3) US5744448A (fr)
EP (2) EP0575357B1 (fr)
JP (1) JP3581148B2 (fr)
KR (1) KR100245250B1 (fr)
AT (2) ATE224446T1 (fr)
AU (1) AU671417B2 (fr)
CA (1) CA2106061C (fr)
DE (2) DE69232779T2 (fr)
DK (1) DK0575357T3 (fr)
ES (1) ES2183806T3 (fr)
FI (1) FI109360B (fr)
GE (1) GEP19991604B (fr)
LT (1) LT3973B (fr)
LV (1) LV10724B (fr)
MX (1) MX9203350A (fr)
NO (1) NO315517B1 (fr)
RU (1) RU2193599C2 (fr)
UA (1) UA43826C2 (fr)
WO (1) WO1992016620A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3949893A (en) * 1992-03-30 1993-11-08 Akzo Nobel N.V. Human gonadotropin receptor (FSH receptor)
SI0894141T1 (en) 1996-02-20 2005-10-31 Applied Research Systems Ars Holding N.V. Hybrid proteins which form heterodimers
EP0910648A1 (fr) * 1996-04-15 1999-04-28 The Board Of Trustees Of The Leland Stanford Junior University Compositions solubles de recepteurs couples a des proteine g du domaine transmembranaire 7 et leurs procedes de fabrication
US6521641B1 (en) 1998-10-08 2003-02-18 Allergan, Inc. Male anti-fertility agents
AU5137900A (en) 1999-05-28 2000-12-18 University Of Cincinnati, The Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use
US20040077041A1 (en) * 2000-05-18 2004-04-22 Shyam Ramakrishnan Regulation of human follicle stimulating hormone-like g protein -coupled receptor
WO2003062396A2 (fr) * 2002-01-23 2003-07-31 Arena Pharmaceuticals, Inc. Versions non endogenes de recepteur humain fshr couples aux proteines g
EP1466620A1 (fr) * 2003-04-11 2004-10-13 AXXAM S.r.l. Compositions permettant de moduler le récepteur de l'hormone folliculostimulante et ses applications thérapeutiques
US20100061976A1 (en) * 2008-07-24 2010-03-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652450A (en) * 1984-08-31 1987-03-24 Research Corporation Bacterial FSH binding inhibitor
US4761371A (en) 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US4921808A (en) * 1986-06-25 1990-05-01 The Albany Medical College Of Union University Method for determining follicle stimulating hormone
US4960700A (en) * 1986-12-24 1990-10-02 Genentech, Inc. Compositions and methods for the synthesis and assay of a mammalian enkephalinase
US5057417A (en) 1987-06-12 1991-10-15 Genentech, Inc. Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein
EP1199361A3 (fr) * 1989-05-05 2004-03-10 Genentech Inc. Molécules réceptrices des hormones glycoprotéiques. Leurs utilisations
US5155218A (en) * 1990-05-08 1992-10-13 Neurogenetic Corporation Dna encoding human 5-ht1d receptors

Also Published As

Publication number Publication date
RU2193599C2 (ru) 2002-11-27
LT3973B (en) 1996-05-27
FI109360B (fi) 2002-07-15
WO1992016620A1 (fr) 1992-10-01
DE69232779T2 (de) 2003-01-30
AU671417B2 (en) 1996-08-29
EP0575357A1 (fr) 1993-12-29
EP1167385B1 (fr) 2011-04-13
MX9203350A (es) 1992-08-01
DE69232779D1 (de) 2002-10-24
CA2106061C (fr) 2008-10-07
ES2183806T3 (es) 2003-04-01
EP1167385A3 (fr) 2003-04-16
CA2106061A1 (fr) 1992-09-16
ATE505486T1 (de) 2011-04-15
FI934023A0 (fi) 1993-09-14
DE69233805D1 (de) 2011-05-26
FI934023L (fi) 1993-09-14
UA43826C2 (uk) 2002-01-15
NO933272D0 (no) 1993-09-14
NO933272L (no) 1993-09-14
LV10724B (en) 1995-12-20
EP1167385A2 (fr) 2002-01-02
DK0575357T3 (da) 2002-11-25
JP3581148B2 (ja) 2004-10-27
EP0575357B1 (fr) 2002-09-18
AU1251492A (en) 1992-10-21
GEP19991604B (en) 1999-04-29
US6372711B1 (en) 2002-04-16
JPH06505157A (ja) 1994-06-16
LV10724A (lv) 1995-06-20
US5744448A (en) 1998-04-28
ATE224446T1 (de) 2002-10-15
KR100245250B1 (en) 2000-02-15
LTIP1631A (en) 1995-07-25
US6121016A (en) 2000-09-19

Similar Documents

Publication Publication Date Title
US6261800B1 (en) Luteinizing hormone/choriogonadotropin (LH/CG) receptor
WO1995029685A1 (fr) Antagonistes de l'activine utilises comme nouveaux contraceptifs
US20210054041A1 (en) Glycoprotein Hormone Long-Acting Superagonists
EP0614975B1 (fr) Molécules réceptrices d'hormone de glycoprotéine
EP0575357B1 (fr) Recepteur de l'hormone folliculostimulante humaine
EP3065766A1 (fr) Superagonistes a longue duree d'action a base d'hormone glycoproteique
KR20040039320A (ko) 인간호르몬의 비키메라 유사체를 제조하는 방법
US10457713B2 (en) Glycoprotein hormone long-acting superagonists
US20050042205A1 (en) Glycoprotein hormone receptor molecules
KR20000010866A (ko) 당단백질 호르몬 초활성 효능약

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA, 0125 OSLO, NO

MK1K Patent expired